Linden Capital L.P. short positions
As of 2026-11-10, Linden Capital L.P. reports short positions of 0.5% or more in 1 stocks. It ranks #44 of 68 institutions by number of stocks shorted. Its largest position is Nxera Pharma Co.,Ltd. (2.93%). Its first report on record is from 2017-09-06, with 145 reports across 11 stocks so far.
Holdings count stocks with a position of 0.5% or more reported within the past year. How estimates are calculated
Number of Stocks Held Last 5 years, weekly, positions of 0.5% or more
Number of stocks in which this institution reports a short position of 0.5% or more. Hover over (or tap) the chart to see the weekly count and total shares. The peak was 2 stocks on 2020-11-24.
Last 30 Days Latest reports since 2026-10-18
New positions 0
No new positions
Increased 1
- Nxera Pharma Co.,Ltd. 11/10
Decreased (covering) 0
No decreases
Fell below 0.5% / closed 0
No closed positions
Breakdown by Sector Current positions, TSE 33 sectors
Stocks in which Linden Capital L.P. holds a short position of 0.5% or more, grouped by sector. The most common sector is Pharmaceutical (1 stocks).
| Sector | Stocks | Share | Total % |
|---|---|---|---|
| Pharmaceutical | 100.00% | 2.93% |
By market segment
- Prime Market 1
Current Positions Latest report for each stock
| Last report | Stock | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-11-10 | Nxera Pharma Co.,Ltd.4565 | Position 2,714,819 shares | Ratio 2.93% | ▲0.14% | Holding |
| 2024-09-06 | INFRONEER Holdings Inc.5076 | Position 1,335,966 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2021-09-16 | HEALIOS K.K.4593 | Position 245,942 shares | Ratio 0.48% | ▼0.02% | Below 0.5% |
| 2026-03-03 | NIPPON STEEL CORPORATION5401 | Position 4,271,400 shares | Ratio 0.45% | ▼0.20% | Below 0.5% |
| 2020-01-21 | ONOKEN CO.,LTD.7414 | Position 94,093 shares | Ratio 0.43% | ▼0.21% | Below 0.5% |
| 2020-12-22 | YAOKO CO.,LTD8279 | Position 170,028 shares | Ratio 0.43% | ▼0.15% | Below 0.5% |
| 2021-02-05 | MARUWA UNYU KIKAN CO.,LTD.9090 | Position 299,932 shares | Ratio 0.23% | ▼0.28% | Below 0.5% |
| 2022-01-06 | giftee Inc.4449 | Position 58,950 shares | Ratio 0.22% | ▼0.37% | Below 0.5% |
| 2017-09-06 | Topre Corporation5975 | Position 0 shares | Ratio 0.00% | ▼1.40% | Closed |
| 2025-12-10 | NTN CORPORATION6472 | Position 0 shares | Ratio 0.00% | ▼2.38% | Closed |
| 2017-12-21 | PARAMOUNT BED HOLDINGS CO.,LTD.7817 | Position 0 shares | Ratio 0.00% | ▼1.40% | Closed |
Longest-Held Positions Current positions, oldest first report first
| Stock | First reported | Days | Current % |
|---|---|---|---|
| Nxera Pharma Co.,Ltd.4565 | 2020-11-24 | 2,184 days | 2.93% |
The first-reported date is when this institution first disclosed a position in the stock. The period may include times when the position fell below 0.5%.
Institutions Shorting the Same Stocks By number of overlapping stocks
Institutions reporting short positions of 0.5% or more in the same stocks that Linden Capital L.P. currently holds (1 stocks).
| Short Sellers | Overlapping stocks | Overlap |
|---|---|---|
| BNP Paribas Financial Markets SNC | 1 | 100.00% |
| Citigroup Global Markets Limited | 1 | 100.00% |
| Nomura International plc | 1 | 100.00% |
| UBS AG | 1 | 100.00% |
Reports by Year By calculation year
| Year | Reports | Stocks reported |
|---|---|---|
| 2026 | 2 | |
| 2025 | 2 | |
| 2024 | 2 | |
| 2023 | 1 | |
| 2022 | 2 | |
| 2021 | 4 | |
| 2020 | 3 | |
| 2017 | 2 |
Disclosure History Latest 100
| Trade date | Stock | Position (shares) | Ratio | Change | Short seller |
|---|---|---|---|---|---|
| 2026-11-10 | Nxera Pharma Co.,Ltd.4565 | Position 2,714,819 shares | Ratio 2.93% | ▲0.14% | Linden Capital L.P. |
| 2026-11-09 | Nxera Pharma Co.,Ltd.4565 | Position 2,584,038 shares | Ratio 2.79% | ▲0.32% | Linden Capital L.P. |
| 2026-11-06 | Nxera Pharma Co.,Ltd.4565 | Position 2,285,856 shares | Ratio 2.47% | ▼0.22% | Linden Capital L.P. |
| 2026-11-05 | Nxera Pharma Co.,Ltd.4565 | Position 2,484,716 shares | Ratio 2.69% | ▲0.30% | Linden Capital L.P. |
| 2026-11-04 | Nxera Pharma Co.,Ltd.4565 | Position 2,211,541 shares | Ratio 2.39% | ▼0.26% | Linden Capital L.P. |
| 2026-11-02 | Nxera Pharma Co.,Ltd.4565 | Position 2,452,619 shares | Ratio 2.65% | ▲0.40% | Linden Capital L.P. |
| 2026-11-02 | Nxera Pharma Co.,Ltd.4565 | Position 2,082,112 shares | Ratio 2.25% | ▼0.60% | Linden Capital L.P. |
| 2026-10-29 | Nxera Pharma Co.,Ltd.4565 | Position 2,643,312 shares | Ratio 2.85% | ▲0.14% | Linden Capital L.P. |
| 2026-10-28 | Nxera Pharma Co.,Ltd.4565 | Position 2,508,740 shares | Ratio 2.71% | ▲0.80% | Linden Capital L.P. |
| 2026-10-26 | Nxera Pharma Co.,Ltd.4565 | Position 1,765,642 shares | Ratio 1.91% | ▲0.05% | Linden Capital L.P. |
| 2026-10-21 | Nxera Pharma Co.,Ltd.4565 | Position 1,721,237 shares | Ratio 1.86% | ▲0.14% | Linden Capital L.P. |
| 2026-09-11 | Nxera Pharma Co.,Ltd.4565 | Position 1,595,762 shares | Ratio 1.72% | ▼0.17% | Linden Capital L.P. |
| 2026-05-15 | Nxera Pharma Co.,Ltd.4565 | Position 1,730,947 shares | Ratio 1.89% | ▼0.05% | Linden Capital L.P. |
| 2026-05-11 | Nxera Pharma Co.,Ltd.4565 | Position 1,782,938 shares | Ratio 1.94% | ▲0.19% | Linden Capital L.P. |
| 2026-05-08 | Nxera Pharma Co.,Ltd.4565 | Position 1,604,520 shares | Ratio 1.75% | ▲0.41% | Linden Capital L.P. |
| 2026-04-24 | Nxera Pharma Co.,Ltd.4565 | Position 1,210,330 shares | Ratio 1.34% | ▼0.13% | Linden Capital L.P. |
| 2026-04-17 | Nxera Pharma Co.,Ltd.4565 | Position 1,328,632 shares | Ratio 1.47% | ▼0.04% | Linden Capital L.P. |
| 2026-04-16 | Nxera Pharma Co.,Ltd.4565 | Position 1,367,458 shares | Ratio 1.51% | ▲0.08% | Linden Capital L.P. |
| 2026-04-01 | Nxera Pharma Co.,Ltd.4565 | Position 1,289,325 shares | Ratio 1.43% | ▲0.14% | Linden Capital L.P. |
| 2026-03-16 | Nxera Pharma Co.,Ltd.4565 | Position 1,164,698 shares | Ratio 1.29% | ▼0.03% | Linden Capital L.P. |
| 2026-03-11 | Nxera Pharma Co.,Ltd.4565 | Position 1,201,798 shares | Ratio 1.32% | ▲0.10% | Linden Capital L.P. |
| 2026-03-03 | NIPPON STEEL CORPORATION5401 | Position 4,271,400 shares | Ratio 0.45% | ▼0.20% | Linden Capital L.P. |
| 2026-03-02 | NIPPON STEEL CORPORATION5401 | Position 6,219,600 shares | Ratio 0.65% | ▼0.09% | Linden Capital L.P. |
| 2026-02-27 | Nxera Pharma Co.,Ltd.4565 | Position 1,106,536 shares | Ratio 1.22% | ▲0.07% | Linden Capital L.P. |
| 2026-02-26 | NIPPON STEEL CORPORATION5401 | Position 7,040,800 shares | Ratio 0.74% | ▼0.39% | Linden Capital L.P. |
| 2026-02-25 | NIPPON STEEL CORPORATION5401 | Position 10,755,600 shares | Ratio 1.13% | ▲0.95% | Linden Capital L.P. |
| 2026-01-13 | Nxera Pharma Co.,Ltd.4565 | Position 1,048,156 shares | Ratio 1.15% | ▼0.05% | Linden Capital L.P. |
| 2026-01-07 | Nxera Pharma Co.,Ltd.4565 | Position 1,091,869 shares | Ratio 1.20% | ▲0.07% | Linden Capital L.P. |
| 2025-12-15 | Nxera Pharma Co.,Ltd.4565 | Position 1,023,248 shares | Ratio 1.03% | ±0.00% | Linden Capital L.P. |
| 2025-12-10 | NTN CORPORATION6472 | Position 0 shares | Ratio 0.00% | ▼2.38% | Linden Capital L.P. |
| 2025-12-02 | Nxera Pharma Co.,Ltd.4565 | Position 927,606 shares | Ratio 1.03% | ▲0.05% | Linden Capital L.P. |
| 2025-12-01 | Nxera Pharma Co.,Ltd.4565 | Position 886,714 shares | Ratio 0.98% | ▲0.23% | Linden Capital L.P. |
| 2025-11-28 | NTN CORPORATION6472 | Position 12,688,179 shares | Ratio 2.38% | ▲0.12% | Linden Capital L.P. |
| 2025-11-26 | NTN CORPORATION6472 | Position 12,019,343 shares | Ratio 2.26% | ▲0.18% | Linden Capital L.P. |
| 2025-11-20 | NTN CORPORATION6472 | Position 11,087,059 shares | Ratio 2.08% | ▼0.05% | Linden Capital L.P. |
| 2025-11-14 | NTN CORPORATION6472 | Position 11,342,252 shares | Ratio 2.13% | ▲0.09% | Linden Capital L.P. |
| 2025-11-10 | NTN CORPORATION6472 | Position 10,873,136 shares | Ratio 2.04% | ▲0.11% | Linden Capital L.P. |
| 2025-11-06 | NTN CORPORATION6472 | Position 10,278,102 shares | Ratio 1.93% | ▲0.08% | Linden Capital L.P. |
| 2025-11-04 | NTN CORPORATION6472 | Position 9,869,256 shares | Ratio 1.85% | ▲0.28% | Linden Capital L.P. |
| 2025-10-31 | NTN CORPORATION6472 | Position 8,374,283 shares | Ratio 1.57% | ▼0.29% | Linden Capital L.P. |
| 2025-10-30 | NTN CORPORATION6472 | Position 9,897,376 shares | Ratio 1.86% | ▲0.08% | Linden Capital L.P. |
| 2025-10-29 | NTN CORPORATION6472 | Position 9,473,175 shares | Ratio 1.78% | ▼0.03% | Linden Capital L.P. |
| 2025-10-29 | Nxera Pharma Co.,Ltd.4565 | Position 675,455 shares | Ratio 0.75% | ▼0.13% | Linden Capital L.P. |
| 2025-10-28 | NTN CORPORATION6472 | Position 9,617,807 shares | Ratio 1.81% | ▲0.07% | Linden Capital L.P. |
| 2025-10-24 | NTN CORPORATION6472 | Position 9,262,802 shares | Ratio 1.74% | ▲0.14% | Linden Capital L.P. |
| 2025-10-22 | NTN CORPORATION6472 | Position 8,551,484 shares | Ratio 1.60% | ▲0.22% | Linden Capital L.P. |
| 2025-10-21 | NTN CORPORATION6472 | Position 7,364,478 shares | Ratio 1.38% | ▲0.15% | Linden Capital L.P. |
| 2025-10-14 | NTN CORPORATION6472 | Position 6,543,927 shares | Ratio 1.23% | ▼0.10% | Linden Capital L.P. |
| 2025-10-06 | NTN CORPORATION6472 | Position 7,063,986 shares | Ratio 1.33% | ▲0.08% | Linden Capital L.P. |
| 2025-10-03 | NTN CORPORATION6472 | Position 6,641,366 shares | Ratio 1.25% | ▲0.15% | Linden Capital L.P. |
| 2025-09-26 | NTN CORPORATION6472 | Position 5,967,858 shares | Ratio 1.06% | ±0.00% | Linden Capital L.P. |
| 2025-09-26 | Nxera Pharma Co.,Ltd.4565 | Position 862,832 shares | Ratio 0.88% | ▼0.07% | Linden Capital L.P. |
| 2025-09-25 | NTN CORPORATION6472 | Position 5,653,934 shares | Ratio 1.06% | ▲0.08% | Linden Capital L.P. |
| 2025-09-24 | NTN CORPORATION6472 | Position 5,235,050 shares | Ratio 0.98% | ▼0.11% | Linden Capital L.P. |
| 2025-09-19 | Nxera Pharma Co.,Ltd.4565 | Position 862,832 shares | Ratio 0.95% | ▲0.13% | Linden Capital L.P. |
| 2025-09-08 | NTN CORPORATION6472 | Position 5,794,573 shares | Ratio 1.09% | ▲0.91% | Linden Capital L.P. |
| 2025-09-08 | Nxera Pharma Co.,Ltd.4565 | Position 741,679 shares | Ratio 0.82% | ▲0.05% | Linden Capital L.P. |
| 2025-06-20 | Nxera Pharma Co.,Ltd.4565 | Position 699,322 shares | Ratio 0.77% | ▼0.03% | Linden Capital L.P. |
| 2025-06-02 | Nxera Pharma Co.,Ltd.4565 | Position 725,264 shares | Ratio 0.80% | ▲0.03% | Linden Capital L.P. |
| 2025-05-12 | Nxera Pharma Co.,Ltd.4565 | Position 694,039 shares | Ratio 0.77% | ▼0.10% | Linden Capital L.P. |
| 2025-05-01 | Nxera Pharma Co.,Ltd.4565 | Position 781,112 shares | Ratio 0.87% | ▲0.14% | Linden Capital L.P. |
| 2025-04-04 | Nxera Pharma Co.,Ltd.4565 | Position 658,473 shares | Ratio 0.73% | ▼0.11% | Linden Capital L.P. |
| 2025-04-02 | Nxera Pharma Co.,Ltd.4565 | Position 753,848 shares | Ratio 0.84% | ▼0.08% | Linden Capital L.P. |
| 2025-03-13 | Nxera Pharma Co.,Ltd.4565 | Position 823,375 shares | Ratio 0.92% | ▲0.08% | Linden Capital L.P. |
| 2025-03-07 | Nxera Pharma Co.,Ltd.4565 | Position 757,339 shares | Ratio 0.93% | ±0.00% | Linden Capital L.P. |
| 2025-03-03 | Nxera Pharma Co.,Ltd.4565 | Position 839,224 shares | Ratio 0.93% | ▲0.05% | Linden Capital L.P. |
| 2025-02-20 | Nxera Pharma Co.,Ltd.4565 | Position 789,130 shares | Ratio 0.88% | ▼0.04% | Linden Capital L.P. |
| 2025-02-18 | Nxera Pharma Co.,Ltd.4565 | Position 828,780 shares | Ratio 0.92% | ▼0.03% | Linden Capital L.P. |
| 2025-02-18 | Nxera Pharma Co.,Ltd.4565 | Position 954,690 shares | Ratio 1.06% | ▲0.11% | Linden Capital L.P. |
| 2025-02-03 | Nxera Pharma Co.,Ltd.4565 | Position 854,125 shares | Ratio 0.95% | ▼0.12% | Linden Capital L.P. |
| 2025-01-14 | Nxera Pharma Co.,Ltd.4565 | Position 964,783 shares | Ratio 1.07% | ▼0.10% | Linden Capital L.P. |
| 2025-01-06 | Nxera Pharma Co.,Ltd.4565 | Position 1,048,506 shares | Ratio 1.17% | ▼0.10% | Linden Capital L.P. |
| 2024-12-17 | Nxera Pharma Co.,Ltd.4565 | Position 1,137,579 shares | Ratio 1.27% | ▼0.11% | Linden Capital L.P. |
| 2024-12-13 | Nxera Pharma Co.,Ltd.4565 | Position 1,242,139 shares | Ratio 1.38% | ▼0.10% | Linden Capital L.P. |
| 2024-11-18 | Nxera Pharma Co.,Ltd.4565 | Position 1,333,276 shares | Ratio 1.48% | ▼0.06% | Linden Capital L.P. |
| 2024-10-16 | Nxera Pharma Co.,Ltd.4565 | Position 1,386,401 shares | Ratio 1.54% | ▼0.15% | Linden Capital L.P. |
| 2024-10-02 | Nxera Pharma Co.,Ltd.4565 | Position 1,514,707 shares | Ratio 1.69% | ▼0.10% | Linden Capital L.P. |
| 2024-09-17 | Nxera Pharma Co.,Ltd.4565 | Position 1,609,881 shares | Ratio 1.79% | ▼0.06% | Linden Capital L.P. |
| 2024-09-06 | INFRONEER Holdings Inc.5076 | Position 1,335,966 shares | Ratio 0.49% | ▼0.01% | Linden Capital L.P. |
| 2024-09-06 | Nxera Pharma Co.,Ltd.4565 | Position 1,666,666 shares | Ratio 1.85% | ▼0.07% | Linden Capital L.P. |
| 2024-09-04 | Nxera Pharma Co.,Ltd.4565 | Position 1,729,646 shares | Ratio 1.92% | ▼0.08% | Linden Capital L.P. |
| 2024-08-30 | Nxera Pharma Co.,Ltd.4565 | Position 1,800,979 shares | Ratio 2.00% | ▼0.12% | Linden Capital L.P. |
| 2024-08-29 | Nxera Pharma Co.,Ltd.4565 | Position 1,909,856 shares | Ratio 2.12% | ▼0.33% | Linden Capital L.P. |
| 2024-08-20 | Nxera Pharma Co.,Ltd.4565 | Position 2,198,005 shares | Ratio 2.45% | ▲0.09% | Linden Capital L.P. |
| 2024-08-16 | INFRONEER Holdings Inc.5076 | Position 1,374,374 shares | Ratio 0.50% | ▲0.02% | Linden Capital L.P. |
| 2024-08-16 | Nxera Pharma Co.,Ltd.4565 | Position 2,125,734 shares | Ratio 2.36% | ▲0.12% | Linden Capital L.P. |
| 2024-08-14 | Nxera Pharma Co.,Ltd.4565 | Position 2,017,794 shares | Ratio 2.24% | ▲0.12% | Linden Capital L.P. |
| 2024-08-09 | INFRONEER Holdings Inc.5076 | Position 1,328,610 shares | Ratio 0.48% | ▼0.02% | Linden Capital L.P. |
| 2024-08-07 | INFRONEER Holdings Inc.5076 | Position 1,373,418 shares | Ratio 0.50% | ▲0.08% | Linden Capital L.P. |
| 2024-08-07 | Nxera Pharma Co.,Ltd.4565 | Position 1,906,102 shares | Ratio 2.12% | ▲0.07% | Linden Capital L.P. |
| 2024-08-06 | Nxera Pharma Co.,Ltd.4565 | Position 1,844,248 shares | Ratio 2.05% | ▲0.08% | Linden Capital L.P. |
| 2024-08-05 | INFRONEER Holdings Inc.5076 | Position 1,143,448 shares | Ratio 0.42% | ▼0.17% | Linden Capital L.P. |
| 2024-08-05 | Nxera Pharma Co.,Ltd.4565 | Position 1,765,125 shares | Ratio 1.97% | ▼0.25% | Linden Capital L.P. |
| 2024-08-02 | Nxera Pharma Co.,Ltd.4565 | Position 1,981,940 shares | Ratio 2.22% | ▼0.19% | Linden Capital L.P. |
| 2024-07-24 | Nxera Pharma Co.,Ltd.4565 | Position 2,159,335 shares | Ratio 2.41% | ▲0.11% | Linden Capital L.P. |
| 2024-06-27 | Nxera Pharma Co.,Ltd.4565 | Position 2,059,562 shares | Ratio 2.30% | ▲0.08% | Linden Capital L.P. |
| 2024-06-25 | Nxera Pharma Co.,Ltd.4565 | Position 1,981,752 shares | Ratio 2.22% | ▲0.03% | Linden Capital L.P. |
| 2023-06-15 | Sosei Group Corporation4565 | Position 2,580,975 shares | Ratio 3.15% | ▼0.13% | Linden Capital L.P. |
| 2022-06-01 | Sosei Group Corporation4565 | Position 1,020,277 shares | Ratio 1.25% | ▼0.14% | Linden Capital L.P. |
| 2022-01-21 | Sosei Group Corporation4565 | Position 1,134,236 shares | Ratio 1.48% | ±0.00% | Linden Capital L.P. |
FAQ
- How many stocks is Linden Capital L.P. shorting now?
- As of 2026-11-10, it reports short positions of 0.5% or more in 1 stocks, 2,714,819 shares in total.
- Which stock has the largest short position by Linden Capital L.P.?
- Nxera Pharma Co.,Ltd., at 2.93% of shares outstanding (as of 2026-11-10).
- Which stocks has Linden Capital L.P. recently started shorting?
- No new positions of 0.5% or more in the last 30 days.
- Where does this data come from?
- It comes from the short position disclosures published by Japan Exchange Group (JPX). Anyone holding a short position of 0.5% or more of shares outstanding must report it, and KabuNote imports these reports daily. Once a position falls below 0.5%, reporting is no longer required, so later balances are not published.
Other Major Short Sellers By number of stocks shorted
- Barclays Capital Securities Ltd 635
- GOLDMAN SACHS INTERNATIONAL 450
- Morgan Stanley MUFG Securities Co., Ltd. 430
- JPM Securities Japan Co Ltd. 198
- Nomura International plc 188
- Citigroup Global Markets Limited 87
- MERRILL LYNCH INTERNATIONAL 77
- Daiwa Securities Co. Ltd. 72
- Diversified Select Opportunities, LLC 70
- UBS AG 50
- Barclays Bank PLC 46
- BNP Paribas Financial Markets SNC 43
- Arrowstreet Capital, Limited Partnership 30
- Nomura Securities Co., Ltd. 29
- Numeric Investors LLC 24
- Nomura Asset Management Singapore Limited 19
- Jump Trading Pacific Pte Ltd 15
- Individual 14
- J.P. MORGAN SECURITIES PLC 11
- Man Solutions Limited 9